Olaparib as a new standard of care in castration-resistant prostate cancer Olaparib as a new standard of care in castration-resistant prostate cancer Clinical Practice Read more
Clinical Practice The Melanoma Patient Education Atlas as a new supportive tool for melanoma health care profess... Read more
Clinical Practice Post-operative radiotherapy in adenoid cystic carcinoma patients produces clinical benefit Read more
Clinical Practice New blood test identifies which subtypes of pancreatic cancer respond to treatment Read more
Clinical Practice Long-term benefit with encorafenib/binimetinib in patients with mutated melanoma Read more
Clinical Practice ESMO issues first recommendations on using next-generation sequencing for advanced cancers Read more
Clinical Practice Flemish hospitals join forces in secure manner to share digital patient data Read more